Skip to main content

Show 26 results Show all

Can DMPA-SC Self-injection Bridge a Family Planning Access Gap in Humanitarian Settings?

Humanitarian crises and disease outbreaks exacerbate the barriers that women face when seeking reproductive health services. They also highlight a timeless truth: women must be able to manage their own sexual and reproductive health—especially in a crisis when health systems are at their weakest.

On November 17, 2021, the PATH-JSI DMPA-SC Access Collaborative hosted this webinar on making self-care interventions available, including DMPA-SC self-injection, in humanitarian settings. Through this virtual discussion, we addressed key challenges in humanitarian settings that need to be addressed in order to leverage the potential of self-injection as an option to ease access to family planning in the context of a full method mix.

Discussion highlights included:

  • Programmatic or regulatory actions that need to be implemented
  • Country-specific cultural barriers affecting demand generation in humanitarian settings
  • Supply systems and processes in humanitarian settings compared to national systems
  • Collaboration and data sharing between agencies

This discussion was moderated by George Barigye, Regional Technical Advisor, DMPA-SC Access Collaborative, PATH, Uganda. The keynote introduction was given by Dr. Adewole Adefalu, Country Coordinator, DMPA-SC Access Collaborative, JSI, Nigeria.

Featured panelists:

  • Lilian Ndinda, Maternal and Child Health Coordinator, International Rescue Committee, South Sudan
  • Dr. Arsenia Nhancale, Program Analyst, Family Planning and HIV, United Nations Population Fund, Mozambique
  • Dr. Ronald Nyakoojo, Assistant Public Health Officer, Reproductive Health/HIV, United Nations High Commissioner for Refugees, Uganda
  • Roselline Achola, National Programme Analyst, Family Planning, United Nations Population Fund, Uganda

This discussion encouraged all stakeholders—program implementers, researchers, government officials, health providers, and members of civil society—to consider humanitarian sector perspectives when advocating for policies that advance self-care behaviors and commodities essential to improving health outcomes in crisis settings.

Institutional author(s): PATH, JSI
Publication date: November, 2021

The Highs, Lows, and Squishy Middle of Contraceptive Product Introduction

As part of the Global Health Science and Practice (GHTechX) conference, CHAI, FHI 360, PATH, the Population Council, PSI, and WCG hosted an April 22, 2021 session to synthesize lessons learned across contraceptive introduction of implants, DMPA-SC self-injection, hormonal IUS and other methods. During the session, experts from Kenya, Madagascar, Uganda, and the United States outlined essential steps for the process of contraceptive product introduction, described common challenges, and shared tools and approaches based on experiences with the three methods. Session slides are available below. To watch the recording of this and many other sessions, register for free on the GHTechX website.

Institutional author(s): Clinton Health Access Initiative (CHAI), FHI 360, PATH, Population Council
Publication date: April, 2021

Country DMPA-SC self-injection scale-up plan template

The purpose of this template is to provide users with an evidence-based, adaptable framework for planning a large-scale DMPA-SC self-injection program in any country. It builds on, and acts as an addendum to, the broader National plan for the introduction and scale-up of subcutaneous DMPA (DMPA-SC) template, providing more specificity for self-injection program planning. This template includes links to many resources, such as summaries of scientific evidence, a detailed Program Design Guide, advocacy materials, and training resources. For more information or assistance when developing a country plan for DMPA-SC introduction and scale-up, visit the Access Collaborative technical assistance page or contact FPoptions@path.org.

Institutional author(s): PATH
Publication date: 2020

DMPA-SC self-injection journey map for clients and health workers

This journey map was designed to help program planners with self-injection programs.

Institutional author(s): PATH
Publication date: January, 2020

Tool DMPA-SC self-injection journey map for clients and health workers

DMPA-SC Evidence to Practice meeting report (2019)

In 2019, the Evidence to Practice meeting provided an opportunity to sustain progress and ensure that women have access to this contraceptive innovation as quickly as possible. Delegates from 20 countries across Africa and Asia attended sessions on the state of global scale-up, self-injection evidence and best practices, family planning and HIV integration, the role of the private sector, skills building (monitoring, learning, and evaluation; commodity forecasting; and advocacy), demand generation, innovative training approaches, and a conversation with five DMPA-SC donors.

Institutional author(s): PATH
Publication date: August, 2019

Household waste disposal in DMPA-SC self-injection programs

This presentation highlights the background and resources on the appropriate method of sharps disposal. It presents country practices and evidence on disposal from DMPA-SC self-injection studies and projects, while offering disposal options and considerations for contraceptive self-injection program design and planning. It is designed for in-country stakeholders and decision -makers developing DMPA -SC self-injection programs and plans.

Institutional author(s): PATH, JSI
Publication date: April, 2019